Answers are grounded in this paper and cite their sources.
The study evaluates encapsulation of Enterococcus faecium to enhance antimicrobial effects in a dairy dessert, pointing to potential benefits for food safety.
This study evaluated the protective effect of double-emulsion (W1/O/W2) encapsulation of Enterococcus faecium E297 using milk protein fractions under technological stress and simulated gastrointestinal digestion, as well as its antimicrobial potential in a functional dairy dessert. Encapsulation efficiencies exceeded 90%. E. faecium E297 exhibited moderate adhesion capacity, determined by surface hydrophobicity assay, and antagonistic activity against E. coli, reducing counts by 3.49 log CFU/mL in coculture. Casein-based microcapsules enhanced tolerance to acidic, alkaline, 5% NaCl, and thermal stress and improved stability during storage at 25 °C, maintaining counts above 6.0 log CFU/mL. Moreover, they demonstrated highest resistance during simulated gastrointestinal digestion, with 83.77% survival. In the dairy dessert, E. faecium E297 maintained viable counts consistent with probiotic standards and reduced E. coli by up to 6.0 log CFU/g during storage. These findings indicate that casein-based encapsulation enhances probiotic stability in vitro and may help control E. coli in the product.
No takes yet. Share an insight, caveat, or question.
Mallmann et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: